etoposide has been researched along with zinostatin in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (25.00) | 18.7374 |
1990's | 3 (25.00) | 18.2507 |
2000's | 3 (25.00) | 29.6817 |
2010's | 3 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wiernik, PH | 1 |
Brunner, KW; Cavalli, F | 1 |
Cavalli, F | 1 |
Itoyama, Y; Kochi, M; Kuratsu, J; Uemura, S; Ushio, Y; Yamamoto, H | 1 |
Kobayashi, K; Kyohda, K; Matano, S; Matsuda, T; Nakamura, S; Ohtake, S; Okabe, Y; Okumura, H; Yoshida, T | 1 |
Hamatake, M; Hirano, K; Iguchi, K; Ishida, R; Shibata, M; Usami, Y | 1 |
Hagiwara, K; Harris, CC; Linke, SP; Miura, K; Nagashima, M; Pedeux, R; Riabowol, K; Shiseki, M; Wang, XW; Yokota, J | 1 |
Binet, JL; Delic, J; Deriano, L; Favaudon, V; Guipaud, O; Maciorowski, Z; Merle-BĂ©ral, H; Muller, C; Potocki-Veronese, G; Ricoul, M; Sabatier, L; Salles, B | 1 |
Goodarzi, AA; Jeggo, PA; Riballo, E; Stiff, T; Walker, SA; Woodbine, L | 1 |
Chauchereau, A; Chen, HZ; Chen, Z; Goluszko, E; Leone, G; Lozano, G; Martinez, LA; Post, S | 1 |
Biddle, A; Costea, DE; Fazil, B; Gammon, L; Harper, LJ; Mackenzie, IC | 1 |
Angeloni, C; Bocchini, M; Croco, E; Hrelia, S; Lorenzini, A; Marchionni, S; Sell, C; Stamato, T; Stefanelli, C | 1 |
1 review(s) available for etoposide and zinostatin
Article | Year |
---|---|
[New substances in oncologic therapy].
Topics: Alkylating Agents; Altretamine; Antimetabolites, Antineoplastic; Cisplatin; Dacarbazine; Doxorubicin; Drug Evaluation; Drug Evaluation, Preclinical; Etoposide; Humans; Neoplasms; Nitrosourea Compounds; Razoxane; Tamoxifen; Vinca Alkaloids; Zinostatin | 1978 |
1 trial(s) available for etoposide and zinostatin
Article | Year |
---|---|
[New substances in oncologic therapy].
Topics: Altretamine; Ancitabine; Antimetabolites, Antineoplastic; Antineoplastic Agents; Azacitidine; Cisplatin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Etoposide; Humans; Mitolactol; Nitrosourea Compounds; Razoxane; Remission, Spontaneous; Tamoxifen; Time Factors; Vinca Alkaloids; Zinostatin | 1978 |
10 other study(ies) available for etoposide and zinostatin
Article | Year |
---|---|
The therapy of acute leukemia in the adult: a progress report.
Topics: Acute Disease; Adult; Antineoplastic Agents; Azacitidine; Blood Transfusion; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Granulocytes; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Patient Isolation; Platelet Transfusion; Pneumonia; Prednisone; Pyrimethamine; Remission, Spontaneous; Thioguanine; Vincristine; Zinostatin | 1976 |
Clinical study of intracranial nongerminomatous germ cell tumors producing alpha-fetoprotein.
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Brain Neoplasms; Cerebrospinal Fluid Shunts; Child; Chorionic Gonadotropin; Cisplatin; Cranial Irradiation; Etoposide; Female; Humans; Hydrocephalus; Male; Neoplasm Proteins; Neoplasms, Germ Cell and Embryonal; Pineal Gland; Remission Induction; Vinblastine; Zinostatin | 1990 |
Hemolytic uremic syndrome developing during remission of acute myelomonocytic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Female; Hemolytic-Uremic Syndrome; Humans; Leukemia, Myelomonocytic, Acute; Middle Aged; Mitoxantrone; Plasma Exchange; Platelet Aggregation Inhibitors; Prednisolone; Remission Induction; Zinostatin | 1993 |
Decreased thymosin beta4 in apoptosis induced by a variety of antitumor drugs.
Topics: Actins; Amino Acid Sequence; Antineoplastic Agents; Apoptosis; Cell Division; Diketopiperazines; Etoposide; Humans; Molecular Sequence Data; Neoplasm Proteins; Piperazines; Sequence Homology, Amino Acid; Thymosin; Tumor Cells, Cultured; Zinostatin | 1999 |
DNA damage-inducible gene p33ING2 negatively regulates cell proliferation through acetylation of p53.
Topics: Acetylation; Amino Acid Sequence; Apoptosis; Bleomycin; Cell Division; Cells, Cultured; Cisplatin; Cloning, Molecular; DNA Damage; Doxorubicin; Etoposide; G1 Phase; Gamma Rays; Gene Expression Regulation; Homeodomain Proteins; Humans; Molecular Sequence Data; Protein Processing, Post-Translational; Receptors, Cytoplasmic and Nuclear; Transcription, Genetic; Tumor Cells, Cultured; Tumor Stem Cell Assay; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Zinostatin | 2001 |
Human chronic lymphocytic leukemia B cells can escape DNA damage-induced apoptosis through the nonhomologous end-joining DNA repair pathway.
Topics: Androstadienes; Antibiotics, Antineoplastic; Antigens, Nuclear; Antineoplastic Agents, Phytogenic; Apoptosis; B-Lymphocytes; Blotting, Western; Cell Line, Transformed; Cell Line, Tumor; Cell-Free System; Chromones; Dimerization; DNA; DNA Damage; DNA Repair; DNA-Binding Proteins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Etoposide; Gamma Rays; Humans; Ku Autoantigen; Leukemia, Lymphocytic, Chronic, B-Cell; Morpholines; Okadaic Acid; Phosphatidylinositol 3-Kinases; Protein Binding; Telomere; Time Factors; Wortmannin; Zinostatin | 2005 |
XLF-Cernunnos promotes DNA ligase IV-XRCC4 re-adenylation following ligation.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Animals; Cell Line; Cells, Cultured; Cricetinae; DNA Breaks, Double-Stranded; DNA Ligase ATP; DNA Ligases; DNA Repair; DNA-Binding Proteins; Etoposide; Humans; Mice; Zinostatin | 2009 |
E2F3 is a mediator of DNA damage-induced apoptosis.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line; Cell Line, Tumor; Central Nervous System; Checkpoint Kinase 1; DNA Damage; Doxorubicin; E2F1 Transcription Factor; E2F2 Transcription Factor; E2F3 Transcription Factor; E2F4 Transcription Factor; E2F5 Transcription Factor; Etoposide; Humans; Mice; Phosphorylation; Protein Kinases; RNA, Small Interfering; Whole-Body Irradiation; Zinostatin | 2010 |
Normal and malignant epithelial cells with stem-like properties have an extended G2 cell cycle phase that is associated with apoptotic resistance.
Topics: Antineoplastic Agents; Apoptosis; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Cell Shape; Cisplatin; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Etoposide; G2 Phase; Humans; Hyaluronan Receptors; Keratinocytes; Neoplastic Stem Cells; Radiation Tolerance; Time Factors; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Ultraviolet Rays; Zinostatin | 2010 |
DNA Damage Detection by 53BP1: Relationship to Species Longevity.
Topics: Animals; Cattle; Cell Cycle Checkpoints; Cell Line; Chiroptera; Cyclin A; Cytotoxins; DNA Damage; DNA Fragmentation; Dogs; Etoposide; Fibroblasts; Genomic Instability; Histones; Humans; Life Expectancy; Longevity; Mice; Micronuclei, Chromosome-Defective; Micronucleus Tests; NIMA-Related Kinases; Topoisomerase II Inhibitors; Tumor Suppressor p53-Binding Protein 1; Zinostatin | 2017 |